ALEXANDRIA, Va., July 16 -- United States Patent no. 12,668,620, issued on June 30, was assigned to ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (New York).

"Neutralizing monoclonal anti-VP1 antibodies to BK virus" was invented by Thomas M. Moran (New York), Thomas A. Kraus (New York), James A. Duty (New York) and Domenico Tortorella (New York).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided herein are monoclonal antibodies targeting VP1 of polyomaviruses including BK virus. Also provided are methods of treating or preventing polyomavirus infections using one or more antibodies."

The patent was filed on March 11, 2022, under Application No. 18/549,974.

*For further information, including images, charts a...